. 2018 Jul 25;62:10.29219/fnr.v62.1398. doi: 10.29219/fnr.v62.1398

Table 1.

Effects of pretreatment with FPLR on the liver and spleen index in CCl₄-treated mice ( $\bar{X}$ ± SD, n = 10)

Groups	Liver index	Spleen index
Normal control	49.95 ± 1.69^d	3.51 ± 0.35^b
CCl₄-treated	60.42 ± 1.47^a	4.01 ± 0.58^a
Bifendate (100 mg/kg bw) + CCl₄	53.98 ± 1.11^bc	3.71 ± 0.23^ab
FPLR (50 mg/kg bw) + CCl₄	55.01 ± 2.36^b	3.89 ± 0.36^a
FPLR (100 mg/kg bw) + CCl₄	54.04 ± 1.25^bc	3.82 ± 0.24^ab
FPLR (200 mg/kg bw) + CCl₄	52.99 ± 1.66^c	3.73 ± 0.31^ab

Data are shown as mean values ± SD for the 10 mice in each group. Values within a column with different letters indicate significant difference among different groups at p < 0.05.